Arcadia Biosciences, Inc.

RKDA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$4-$14-$16-$16
Dep. & Amort.$1$0$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$2
Change in WC-$1-$3$1-$3
Other Non-Cash-$5$0-$1-$9
Operating Cash Flow-$10-$15-$14-$26
Investing Activities
PP&E Inv.-$2-$0-$0-$1
Net Acquisitions$0$1$1-$4
Inv. Purchases$0-$8$0$0
Inv. Sales/Matur.$5$3$0$22
Other Inv. Act.$4$0$1$0
Investing Cash Flow$7-$4$1$17
Financing Activities
Debt Repay.$0$0$0-$2
Stock Issued$0$6$5$25
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$1
Financing Cash Flow$0$6$5$22
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$14-$8$13
Supplemental Information
Beg. Cash$7$21$29$16
End Cash$4$7$21$29
Free Cash Flow-$10-$15-$14-$27
Arcadia Biosciences, Inc. (RKDA) Financial Statements & Key Stats | AlphaPilot